Open-label Placebo

Open-Label Placebo is a therapeutic intervention in which an inert substance or sham treatment is administered transparently, without deception, to patients who are fully informed of its lack of pharmacological activity, thereby distinguishing it from conventional placebo use by maintaining patient awareness and consent.

542

Publications

51.5K

Citations

4.8K

Authors

1.7K

Institutions

Publications per year

2017–2026

219

Variants

OlpOpen-label Placebos

Authors

4.8K

  1. TJ
    Ted J. Kaptchuk

    Harvard University, United States

    18 publications · 2.4K citations

    16

    h-index

  2. IK
    Irving Kirsch

    University of Connecticut, United States

    12 publications · 1.9K citations

    12

    h-index

  3. PJ
    Philip J. Mease

    University of Washington, United States

    10 publications · 837 citations

    10

    h-index

  4. CL
    Cosima Locher

    University of Basel, Switzerland

    9 publications · 451 citations

    9

    h-index

  5. DV
    Désirée van der Heijde

    Leiden University Medical Center, Netherlands

    7 publications · 607 citations

    7

    h-index

1–5 of 4.8K

Venues

  1. PubMed

    Repository · 30 publications · 1.5K citations

    22

    h-index

  2. Annals of the Rheumatic Diseases

    ARD · 18 publications · 2K citations

    15

    h-index

  3. The Journal of Clinical Psychiatry

    14 publications · 1.1K citations

    14

    h-index

  4. Pain

    13 publications · 1.5K citations

    13

    h-index

  5. Journal of Clinical Oncology

    13 publications · 1.8K citations

    13

    h-index

1–5